La evolución de la prescripción y los costes de los antidepresivos en un área de Atención Primaria (1996-2001)

Lobo, Alberto Ortiz; Serrano, Carolina Lozano; Jiménez, Guevara

doi:10.1016/s1138-3593(05)72970-1

Cited by 4 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…En los últimos años hemos sido testigos del aumento que ha presentado el diagnóstico de depresión, tanto en los servicios de salud mental como en atención primaria 1 . Reflejo de este auge es el incremento en el número de bajas laborales por causa psiquiátrica (en el Área 2 de la Comunidad de Madrid se produjo un incremento de 1,76 bajas/1.000 habitantes-año en 1996 a 3,3 bajas/1.000 habitantes-año en 2001), así como el creciente gasto sanitario derivado de la prescripción de fármacos antidepresivos (el incremento del gasto en estos fármacos aumentó un 160% en atención primaria del Área 2 de la Comunidad de Madrid en el período comprendido entre 1996 y 2001) 2 .…”

Section: Auge De La Depresiónunclassified

Sobrediagnóstico y sobretratamiento del trastorno depresivo mayor en atención primaria: un fenómeno en auge

Adan-Manes¹,

Ayuso-Mateos²

2010

Atención Primaria

View full text Add to dashboard Cite

Section: Auge De La Depresiónunclassified

Sobrediagnóstico y sobretratamiento del trastorno depresivo mayor en atención primaria: un fenómeno en auge

Adan-Manes¹,

Ayuso-Mateos²

2010

Atención Primaria

View full text Add to dashboard Cite

“…While ADs can be effective if well prescribed, almost 50% of prescriptions issued by primary care centres are aimed to treat subjects without a clear psychiatric diagnosis [9]. In addition, the ability to tolerate frustration seems to be progressively declining in the most developed societies, and drugs are frequently sought as a solution to personal and social everyday problems [10].…”

Section: Introductionmentioning

confidence: 99%

Follow up of patients who start treatment with antidepressants: treatment satisfaction, treatment compliance, efficacy and safety

et al. 2013

View full text Add to dashboard Cite

BackgroundMeasuring satisfaction with treatment has proved useful to ascertain the treatment features that are most important to the patients, and to explain increased treatment compliance. However, there are few studies that relate satisfaction to other clinical or self-perceived health status indicators. Recent studies have shown the close relationship between satisfaction with treatment, treatment compliance, and effectiveness. This study attempts to design and validate a scale to evaluate satisfaction with antidepressant drug therapy, assess treatment compliance (self-reported, validated questionnaire, drug accountability and electronic monitorization system), assess efficacy in reducing depressive symptoms and safety in patients who initiate antidepressant drug therapy, as well as to establish predictors of satisfaction, compliance and effectiveness with these drugs.Methods/designThis is an observational longitudinal study with a cohort of adults initiating treatment with antidepressant drugs. A multi-centre study will be performed in which 20 Primary Care practices from Castilla-La Mancha are expected to participate. An initial interview and follow-up visits at 15 days, 1, 3, 6, 9 and 12 months will be conducted with all study participants. 706 subjects will be studied (95% confidence interval, precision ± 3%, expected rate of non-compliance 50%, expected non-responders and lost to follow up rate 15%). The following measurements will be performed: development and validation of a scale of satisfaction with antidepressant therapy, participant and antidepressant characteristics, treatment compliance evaluation (Haynes-Sackett Test, Morisky-Green Test, drug accountability and Medication Event Monitoring System), depression symptom reduction (Hamilton Depression Rating Scale and Montgomery-Asberg Depression Rating Scale), observation of adverse effects, and beliefs about treatment (The Beliefs about Medicines Questionnaire).DiscussionAntidepressant drugs are an extraordinarily important therapeutic group in the pharmacy composition; economic repercussions and social impact associated to their use is clear. Despite their well-established efficacy in clinical trials, treatment non-compliance is a major obstacle to their effectiveness in clinical practice. The proposed study brings about useful conclusions to improve the results of these drugs. Additionally, devising a scale specifically designed to evaluate satisfaction with antidepressant treatment could be of interest in healthcare outcomes research.

show abstract

Medicalización de la vida en la consulta: ¿hacia dónde caminamos?

2013

View full text Add to dashboard Cite

The power of medicine has lately enhanced the idea of medicalizing any aspects of life that can be perceived as medical problems. Medicine sometimes creates false needs and there is nowadays an increasing number of situations are medicalized with the pretext of treating fake diseases such as spring fatigue, shyness o natural biological processes like menopause. Despite the better life conditions, we now attend more people that complain about discomfort that may have more to do with «feeling sick» than with authentic disease. There is an endless list: sadness, hyperactive children, anorexia, bulimia, vigorexia or problematic teenagers, amongst others. In this article we revise some interventions that, contribute to promote these situations also from the own doctor's office. Everyday adversity acquires today the status of disease, hence the remarkable increase in these consultations in the diverse sanitary services.

show abstract

La evolución de la prescripción y los costes de los antidepresivos en un área de Atención Primaria (1996-2001)

Cited by 4 publications

References 24 publications

Sobrediagnóstico y sobretratamiento del trastorno depresivo mayor en atención primaria: un fenómeno en auge

Sobrediagnóstico y sobretratamiento del trastorno depresivo mayor en atención primaria: un fenómeno en auge

Follow up of patients who start treatment with antidepressants: treatment satisfaction, treatment compliance, efficacy and safety

Medicalización de la vida en la consulta: ¿hacia dónde caminamos?

Contact Info

Product

Resources

About